<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01019733</url>
  </required_header>
  <id_info>
    <org_study_id>HE09-014</org_study_id>
    <nct_id>NCT01019733</nct_id>
  </id_info>
  <brief_title>Intrathecal Stem Cells in Brain Injury</brief_title>
  <acronym>ISC</acronym>
  <official_title>Intrathecal Autologous Stem Cells for Children With Hipoxic/Ischemic Brain Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Dr. Jose E. Gonzalez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Dr. Jose E. Gonzalez</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the plasticity of autologous intrathecal
      hematopoietic cells would improve the neurologic evolution of the pediatric patients with
      hypoxic/ischemic brain injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is accumulating evidence that shows that the placement of hematopoietic cells in the
      brain may increase growth-enhancing factors of axons and generate active neurons in the
      receptor. It has been found that after introducing hematopoietic cells in the subarachnoid
      space of the spinal cord, these cells may be transported through the cerebrospinal fluid and
      can be deliver more efficiently to the injured area, when compared to the intravenous route.
      Patients will be stimulated 4 times and then harvest the bone marrow. Bone marrow will be
      processed in order to obtain hematopoietic cells (CD34+) and minimize the erythrocytes
      amount. A inoculum of 5 to 10mL of stem cells will be infused intrathecally. Patients will be
      evaluated with the &quot;Battelle Developmental Inventory&quot; before the procedure and one and six
      months after that. An MRI will be performed before the procedure and six months after that.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score of &quot;Battelle Developmental Inventory&quot;</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score of &quot;Battelle Developmental Inventory&quot;</measure>
    <time_frame>180 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Hypoxia-Ischemia, Cerebral</condition>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children whom will receive intrathecal autologous stem cells</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intrathecal Autologous Stem Cells</intervention_name>
    <description>Patients will be stimulated with Granulocyte Colony Stimulating Factor (G-CSF) 5 times, harvest bone marrow and infused 8 to 10 mL of stem cells (CD34+) by intrathecal via.</description>
    <arm_group_label>Patients</arm_group_label>
    <other_name>Autologous Stem Cells Transplantation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with hypoxic/ischemic brain injury, with an between 1 month and 18 years,
             regardless the age at the time of injury, time post-injury, or previously received
             therapies, different from ours.

        Exclusion Criteria:

          -  Patients with neurodegenerative or autoimmune diseases.

          -  Patients with active infection in any organ or tissue at the time of entering the
             study, the onset of stimulation with G-CSF or at the procedure.

          -  Patients who do not sign the informed consent form.

        Elimination Criteria

          -  Patients with severe meningeal abnormalities at the time of procedure.

          -  Patients who did not attend subsequent assessments 30 and 180 days after the
             procedure.

          -  Patients who die from causes related to neurological disease within 180 days after
             procedure.

          -  Patients who are diagnosed with neurodegenerative or autoimmune diseases after the
             procedure.

          -  Patients who do not bear the proper stimulation process with Granulocyte Colony
             Stimulating Factor (G-CSF), either by misapplication, lack thereof, or severe adverse
             drug reaction.

          -  Patients choosing to leave the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria C Mancias-Guerra, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Dr. Jose E. Gonzalez</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arturo Garza-Alatorre, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitario Dr. Jose E. Gonzalez</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laura N Rodriguez-Romo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario Dr. Jose E. Gonzalez</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Dr. Jose E. Gonzalez</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Felling RJ, Snyder MJ, Romanko MJ, Rothstein RP, Ziegler AN, Yang Z, Givogri MI, Bongarzone ER, Levison SW. Neural stem/progenitor cells participate in the regenerative response to perinatal hypoxia/ischemia. J Neurosci. 2006 Apr 19;26(16):4359-69.</citation>
    <PMID>16624956</PMID>
  </reference>
  <reference>
    <citation>Glascoe FP, Byrne KE. The usefulness of the Battelle Developmental Inventory Screening Test. Clin Pediatr (Phila). 1993 May;32(5):273-80.</citation>
    <PMID>7686835</PMID>
  </reference>
  <reference>
    <citation>Berls AT, McEwen IR. Battelle developmental inventory. Phys Ther. 1999 Aug;79(8):776-83.</citation>
    <PMID>10440664</PMID>
  </reference>
  <reference>
    <citation>Levison SW, Rothstein RP, Romanko MJ, Snyder MJ, Meyers RL, Vannucci SJ. Hypoxia/ischemia depletes the rat perinatal subventricular zone of oligodendrocyte progenitors and neural stem cells. Dev Neurosci. 2001;23(3):234-47.</citation>
    <PMID>11598326</PMID>
  </reference>
  <reference>
    <citation>Hayashi T, Iwai M, Ikeda T, Jin G, Deguchi K, Nagotani S, Zhang H, Sehara Y, Nagano I, Shoji M, Ikenoue T, Abe K. Neural precursor cells division and migration in neonatal rat brain after ischemic/hypoxic injury. Brain Res. 2005 Mar 15;1038(1):41-9.</citation>
    <PMID>15748871</PMID>
  </reference>
  <reference>
    <citation>Mehta T, Feroz A, Thakkar U, Vanikar A, Shah V, Trivedi H. Subarachnoid placement of stem cells in neurological disorders. Transplant Proc. 2008 May;40(4):1145-7. doi: 10.1016/j.transproceed.2008.03.026.</citation>
    <PMID>18555135</PMID>
  </reference>
  <reference>
    <citation>Goldman SA, Schanz S, Windrem MS. Stem cell-based strategies for treating pediatric disorders of myelin. Hum Mol Genet. 2008 Apr 15;17(R1):R76-83. doi: 10.1093/hmg/ddn052. Review.</citation>
    <PMID>18632701</PMID>
  </reference>
  <reference>
    <citation>Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4080-5.</citation>
    <PMID>9108108</PMID>
  </reference>
  <reference>
    <citation>Mezey E, Key S, Vogelsang G, Szalayova I, Lange GD, Crain B. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1364-9. Epub 2003 Jan 21.</citation>
    <PMID>12538864</PMID>
  </reference>
  <reference>
    <citation>Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, Katakowski M, Zhang LJ, Lu M, Janakiraman N, Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology. 2002 Aug 27;59(4):514-23.</citation>
    <PMID>12196642</PMID>
  </reference>
  <reference>
    <citation>Gordon PH, Yu Q, Qualls C, Winfield H, Dillon S, Greene PE, Fahn S, Breeze RE, Freed CR, Pullman SL. Reaction time and movement time after embryonic cell implantation in Parkinson disease. Arch Neurol. 2004 Jun;61(6):858-61.</citation>
    <PMID>15210522</PMID>
  </reference>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2009</study_first_submitted>
  <study_first_submitted_qc>November 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2009</study_first_posted>
  <last_update_submitted>January 25, 2011</last_update_submitted>
  <last_update_submitted_qc>January 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2011</last_update_posted>
  <responsible_party>
    <name_title>Maria del Consuelo Mancías Guerra</name_title>
    <organization>Hospital Universitario Dr. José E. González</organization>
  </responsible_party>
  <keyword>Hypoxia</keyword>
  <keyword>Ischemia</keyword>
  <keyword>Brain</keyword>
  <keyword>Children</keyword>
  <keyword>Cerebral Palsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hypoxia-Ischemia, Brain</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>September 3, 2014</submitted>
    <returned>September 9, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

